Slough medical technology firm Bxtaccelyon Group secures £2.9m

Prostate cancer diagnosis and treatment technologies are the primary focus of Slough-based Bxtaccelyon Group Limited. The company provides a portfolio of brachytherapy seeds and accessories alongside biopsy hardware such as PrecisionPoint.

A recent funding round has seen the business raise an estimated £2.9m. This capital injection supports the company's focus on early-stage therapy solutions, which include the MRI PRO online self-learning tool designed for medical imaging education.

Incorporated in June 2017, the firm targets healthcare professionals, the National Health Service, and global public and private hospitals. LinkedIn data indicates the organization maintains a workforce of two employees at its headquarters in The Coach House at Grenville Court.

The company recently expanded its leadership team with the appointment of Malcolm Hughes and Saheed Rashid as directors. Documentation for the new shares was filed in July 2026, following an allotment in June 2026.